Preferred Label : Gefapixant;

CISMeF synonym : AF-219;

MeSH Hyperonym : Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-;

UNII : 6K6L7E3F1L;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/lyfnua
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Gefapixant
Gefapixant
gefapixant
drug approval
europe
purinergic P2X3 receptor antagonists
purinergic P2X3 receptor antagonists
purinergic P2X receptor antagonists
purinergic P2X receptor antagonists
Chronic Cough
adult
pregnancy
breast feeding
drug interactions
administration, oral
risk management
product surveillance, postmarketing
Refractory chronic cough (disorder)
Unexplained chronic cough (disorder)
aged
drug evaluation, preclinical

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.